用于感染性休克的氢化可的松，静脉推注还是静脉输注：支持、反对、或许可行。
Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be.
作者信息
Todi Subhash
机构信息
Department of Critical Care, AMRI Hospital, Kolkata, West Bengal, India.
出版信息
Indian J Crit Care Med. 2024 Sep;28(9):816-817. doi: 10.5005/jp-journals-10071-24798. Epub 2024 Aug 31.
Abstract
Todi S. Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be. Indian J Crit Care Med 2024;28(9):816-817.
摘要
托迪·S. 用于感染性休克的氢化可的松，静脉推注还是输注：支持、反对、或许可行。《印度重症监护医学杂志》2024年；28(9):816 - 817。
相似文献
1
Hydrocortisone for Septic Shock, Bolus or Infusion: Pro, Con, May be.用于感染性休克的氢化可的松，静脉推注还是静脉输注：支持、反对、或许可行。
Indian J Crit Care Med. 2024 Sep;28(9):816-817. doi: 10.5005/jp-journals-10071-24798. Epub 2024 Aug 31.
2
Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses vs Continuous Infusion in Septic Shock: A Retrospective Study.脓毒性休克中氢化可的松间歇性大剂量注射与持续输注的高血糖风险评估：一项回顾性研究
Indian J Crit Care Med. 2021 Jan;25(1):29-33. doi: 10.5005/jp-journals-10071-23501.
3
Effect of Continuous Infusion vs Bolus Dose of Hydrocortisone in Septic Shock: A Prospective Randomized Study.氢化可的松持续输注与大剂量冲击给药治疗感染性休克的效果：一项前瞻性随机研究
Indian J Crit Care Med. 2024 Sep;28(9):837-841. doi: 10.5005/jp-journals-10071-24793. Epub 2024 Aug 31.
4
5
Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial.脓毒症休克中氢化可的松间歇性大剂量注射与持续输注的高血糖风险评估：一项前瞻性随机试验
Anesth Essays Res. 2022 Jul-Sep;16(3):321-325. doi: 10.4103/aer.aer_115_22. Epub 2022 Dec 9.
6
Comparison Between Continuous and Intermittent Administration of Hydrocortisone During Septic Shock: A Randomized Controlled Clinical Trial.连续与间断给予氢化可的松治疗脓毒性休克的比较：一项随机对照临床试验。
Shock. 2019 Nov;52(5):481-486. doi: 10.1097/SHK.0000000000001316.
7
Is There an Optimum Duration of Fluid Bolus in Pediatric Septic Shock? A Critical Appraisal of "Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial" by Sankar et al (Pediatr Crit Care Med 2017; 18:e435-e445).小儿感染性休克时液体复苏的最佳输液时间是多久？对 Sankar 等人发表的《小儿感染性休克患者复苏的前 1 小时内，与每次输液 5-10 分钟相比，15-20 分钟输液的效果：一项随机对照试验》一文的批判性评价（儿科危重病医学 2017；18:e435-e445）
Pediatr Crit Care Med. 2018 Apr;19(4):369-371. doi: 10.1097/PCC.0000000000001459.
8
Practices of Initiation of Vasoactive Drugs in Relation to Resuscitation Fluids in Children with Septic Shock: A Prospective Observational Study.脓毒性休克患儿血管活性药物起始使用与复苏液体的关系：一项前瞻性观察研究
Indian J Crit Care Med. 2021 Aug;25(8):928-933. doi: 10.5005/jp-journals-10071-23954.
9
Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients.小剂量氢化可的松推注对感染性休克患者血糖控制的影响。
Intensive Care Med. 2007 Apr;33(4):730-3. doi: 10.1007/s00134-007-0540-3. Epub 2007 Feb 27.
10
Metabolic Resuscitation Using Hydrocortisone, Ascorbic Acid, and Thiamine: Do Individual Components Influence Reversal of Shock Independently?使用氢化可的松、抗坏血酸和硫胺素进行代谢复苏：各成分是否独立影响休克的逆转？
Indian J Crit Care Med. 2020 Aug;24(8):649-652. doi: 10.5005/jp-journals-10071-23515.
本文引用的文献
1
Glycemic control in critically ill patients with or without diabetes.危重症患者合并或不合并糖尿病患者的血糖控制。
BMC Anesthesiol. 2022 Jul 16;22(1):227. doi: 10.1186/s12871-022-01769-4.
2
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动：2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
3
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.氢化可的松联合氟氢可的松治疗脓毒性休克成人患者。
N Engl J Med. 2018 Mar 1;378(9):809-818. doi: 10.1056/NEJMoa1705716.
4
Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.作为2型糖尿病低血糖风险患者识别指标的不同血糖变异性指数
J Diabetes Sci Technol. 2018 Sep;12(5):1007-1015. doi: 10.1177/1932296818758105. Epub 2018 Feb 16.
5
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.辅助糖皮质激素治疗脓毒性休克患者。
N Engl J Med. 2018 Mar 1;378(9):797-808. doi: 10.1056/NEJMoa1705835. Epub 2018 Jan 19.
6
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义（脓毒症-3）》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
7
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).制定脓毒性休克的新定义并评估新的临床标准：用于第三次脓毒症和脓毒性休克国际共识定义（Sepsis-3）。
JAMA. 2016 Feb 23;315(8):775-87. doi: 10.1001/jama.2016.0289.
8
Glycemic variability and outcome in critically ill.危重症患者的血糖变异性与预后
Indian J Crit Care Med. 2014 May;18(5):285-90. doi: 10.4103/0972-5229.132484.
9
Association between intensive care unit-acquired dysglycemia and in-hospital mortality.重症监护病房获得性高血糖与住院死亡率的关系。
Crit Care Med. 2012 Dec;40(12):3180-8. doi: 10.1097/CCM.0b013e3182656ae5.
10
Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.氢化可的松给药方式对感染性休克患者血糖控制的影响：一项前瞻性随机试验。
Crit Care. 2007;11(1):R21. doi: 10.1186/cc5696.
Zotero 插件